Ironwood Pharmaceuticals (IRWD) Leases (2016 - 2025)
Historic Leases for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $9.8 million.
- Ironwood Pharmaceuticals' Leases fell 1447.94% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 1447.94%. This contributed to the annual value of $11.0 million for FY2024, which is 1237.88% down from last year.
- According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Leases is $9.8 million, which was down 1447.94% from $10.2 million recorded in Q2 2025.
- In the past 5 years, Ironwood Pharmaceuticals' Leases ranged from a high of $16.3 million in Q1 2021 and a low of $9.8 million during Q3 2025
- Moreover, its 5-year median value for Leases was $13.3 million (2023), whereas its average is $13.2 million.
- As far as peak fluctuations go, Ironwood Pharmaceuticals' Leases tumbled by 669.46% in 2021, and later tumbled by 1447.94% in 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' Leases (Quarter) stood at $15.4 million in 2021, then dropped by 8.64% to $14.0 million in 2022, then fell by 10.25% to $12.6 million in 2023, then fell by 12.38% to $11.0 million in 2024, then dropped by 11.36% to $9.8 million in 2025.
- Its last three reported values are $9.8 million in Q3 2025, $10.2 million for Q2 2025, and $10.6 million during Q1 2025.